Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
WASHINGTON ? A drug known as sulodexide has failed to show any benefit toward halting kidney failure in people with diabetes and an international trial has been stopped early, a US medical journal said Thursday.
The drug, once seen as a potentially promising treatment to reduce protein in the urine, is made by New York-based Keryx Biopharmaceuticals, which also funded the study that was meant to include more than 2,240 patients worldwide.
However, it was halted after 1,248 people enrolled because there was no difference seen in preventing kidney failure between patients who took sulodexide over a placebo, said the report in the Journal of the American Society of Nephrology.
http://www.google.com/hostednews/af...ocId=CNG.a81c4d237c34121ec07166c0bfa37900.991
The drug, once seen as a potentially promising treatment to reduce protein in the urine, is made by New York-based Keryx Biopharmaceuticals, which also funded the study that was meant to include more than 2,240 patients worldwide.
However, it was halted after 1,248 people enrolled because there was no difference seen in preventing kidney failure between patients who took sulodexide over a placebo, said the report in the Journal of the American Society of Nephrology.
http://www.google.com/hostednews/af...ocId=CNG.a81c4d237c34121ec07166c0bfa37900.991